EUVIMEDEUVIMED entdecken
Vergleichsstudie

Lipoprotein(a) selectively associates with vulnerable coronary plaque phenotypes in comparison with other established risk markers

Rebecca Fisher iD, Chen Gurevitz iD, Edward A Fisher, Jisuk Park, Melissa Aquino, Sascha N Goonewardena, Robert S Rosenson iD

European Heart Journal - Cardiovascular Imaging · 2026

DOI: 10.1093/ehjci/jeag024 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2026. Verfasst von Rebecca Fisher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hauptthemen laut MEDLINE: Lipoprotein(a), Computed Tomography Angiography, Plaque, Atherosclerotic, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Lipoprotein(a) [Lp(a)] is an inherited cardiovascular risk factor. However, its association with coronary plaque characteristics beyond traditional risk enhancers remains unclear. We aimed to evaluate the association between Lp(a) levels and coronary plaque characteristics in asymptomatic primary prevention patients, and to compare its predictive value against other risk enhancers, including LDL particle concentration (LDL-P), high-sensitivity C-reactive protein (hsCRP), and coronary artery calcium (CAC) score. Methods and results We retrospectively analysed 547 asymptomatic patients undergoing coronary computed tomography angiography (CCTA) between 2018 and 2024. Plaque characteristics were assessed using artificial intelligence-based quantitative CCTA. Associations between Lp(a), LDL-P, hsCRP, CAC score, and plaque features were evaluated using multivariable regression adjusted for age and sex. Median age was 56 years, 69.8% were male. Higher Lp(a) was associated with greater total plaque volume (β=23.1 mm³, P = 0.006), calcified plaque (β=11.1 mm³, P = 0.014), non-calcified plaque (β=12.0 mm³, P = 0.027), and low-density non-calcified plaque (LDNCP; β=0.4 mm³, P < 0.001) volumes, as well as increased area stenosis (β=1.9%, P = 0.031) and remodelling index (β=0.02, P = 0.017). In multivariable models, CAC score was the strongest predictor of overall plaque burden, including calcified and non-calcified plaque (P < 0.000), but was not associated with LDNCP. Lp(a) remained independently associated with LDNCP (β=0.45 mm³, P = 0.013), while LDL-P and hsCRP showed no significant associations.

Conclusion

In asymptomatic primary prevention patients, Lp(a) was independently associated with high-risk coronary plaque features, specifically LDNCP, beyond traditional risk enhancers. These findings highlight the unique role of Lp(a) in identifying coronary plaque vulnerability and suggest complementary roles for Lp(a) and CAC in refining cardiovascular risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Computed Tomography AngiographyPlaque, AtheroscleroticCoronary Artery DiseaseHumansMaleFemaleRetrospective StudiesMiddle AgedBiomarkersCoronary AngiographyPhenotypeRisk AssessmentPredictive Value of TestsRisk FactorsC-Reactive Protein

Stichwörter der Autor:innen

coronary artery calcification (CAC) scorecoronary computed tomography angiographycoronary plaquelipoprotein(a)risk factors

Substanzen

Lipoprotein(a)BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, 1428 Madison Avenue, Atran | 8th Floor, New York, NY 10029, USA.
  • Cardiology Division, Rabin Medical Center, Petah-Tikva, Israel.
  • Cleerly Inc., Denver, CO, USA.
  • Department of Cardiology, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Rebecca Fisher, Chen Gurevitz, Robert S Rosenson

Zitieren

APA

Fisher, R., Gurevitz, C., Fisher, E. A., Park, J., Aquino, M., Goonewardena, S. N., & Rosenson, R. S. (2026). Lipoprotein(a) selectively associates with vulnerable coronary plaque phenotypes in comparison with other established risk markers. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jeag024

Vancouver

Fisher R, Gurevitz C, Fisher EA, Park J, Aquino M, Goonewardena SN, et al. Lipoprotein(a) selectively associates with vulnerable coronary plaque phenotypes in comparison with other established risk markers. European Heart Journal - Cardiovascular Imaging. 2026. doi:10.1093/ehjci/jeag024

BibTeX
@article{Fisher2026,
  author = {Fisher, Rebecca and Gurevitz, Chen and Fisher, Edward A and Park, Jisuk and Aquino, Melissa and Goonewardena, Sascha N and Rosenson, Robert S},
  title = {Lipoprotein(a) selectively associates with vulnerable coronary plaque phenotypes in comparison with other established risk markers},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2026},
  doi = {10.1093/ehjci/jeag024}
}
Kostenlos starten →